MyFinsight
Home
Blog
About
Net (loss) income
attributable to merck & co.,...
-$1,335M
(-130.16%↓ Y/Y)
Less net (loss)
income attributable to...
-$2M
(-300.00%↓ Y/Y)
Net (loss) income
-$1,337M
(-130.19%↓ Y/Y)
US
$9,367M
(6.01%↑ Y/Y)
EMEA
$3,920M
(7.13%↑ Y/Y)
Latin America
$875M
(1.86%↑ Y/Y)
Asia Pacific
$820M
(4.46%↑ Y/Y)
Other Countries
$640M
(7.56%↑ Y/Y)
JP
$577M
(-7.83%↓ Y/Y)
CN
$408M
(-8.52%↓ Y/Y)
(loss) income before
taxes
-$683M
(-113.66%↓ Y/Y)
Income tax provision
$654M
(14.54%↑ Y/Y)
Sales
$16,607M
(5.07%↑ Y/Y)
Total costs, expenses
and other
$17,290M
(59.99%↑ Y/Y)
Research and development
$9,741M
(140.64%↑ Y/Y)
Cost of sales
$4,395M
(23.56%↑ Y/Y)
Selling, general and
administrative
$2,904M
(9.63%↑ Y/Y)
Restructuring costs
$151M
(-73.04%↓ Y/Y)
Other (income)
expense, net
-$99M
(-1514.29%↓ Y/Y)
Back
Back
Income Statement
site-logo-svg
Merck & Co., Inc. (MRK)
site-logo-svg
Merck & Co., Inc. (MRK)
source: myfinsight.com